Literature DB >> 332638

Anticomplementary activity of Fusobacterium polymorphum in normal and C4-deficient sources of guinea pig complement.

C E Hawley, W A Falkler.   

Abstract

Fusobacterium polymorphum has been isolated from the gingival crevice in humans and has been implicated in the immunopathology of periodontal diseases. The presence of alternative complement pathway factors in gingival crevice material suggests the contribution of this process in the manifestation of the local host response. A complement consumption assay was used to show that the anticomplementary activity of a cell-wall preparation from F. polymorphum in guinea pig complement progressed optimally at 37 degrees C and suboptimally at 0 degrees C. Similar levels of complement consumption were recorded at both temperatures, but a higher concentration of cell walls was required to demonstrate maximum activity in the cold. Augmentation experiments with additional normal and heat-treated complement showed the presence of heat-labile factors that controlled and limited the consumption of complement to a constant proportion of the total amount present. These same experiments indicated that there were no reactive antibodies in the complement used in the assay. Similar tests with C4-deficient guinea pig sera confirmed that F. polymorphum cell walls were capable of generating alternative complement pathway activity in guinea pig sera.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 332638      PMCID: PMC421203          DOI: 10.1128/iai.18.1.124-129.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  ANTIBODY TO LEPTOTRICHIA BUCCALIS IN HUMAN SERA.

Authors:  S E MERGENHAGEN; W C DEARAUJO
Journal:  Arch Oral Biol       Date:  1965 Jan-Feb       Impact factor: 2.633

2.  EXPERIMENTAL GINGIVITIS IN MAN.

Authors:  H LOE; E THEILADE; S B JENSEN
Journal:  J Periodontol       Date:  1965 May-Jun       Impact factor: 6.993

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C'3 by zymosan.

Authors:  L PILLEMER; I H LEPOW; L BLUM
Journal:  J Immunol       Date:  1953-11       Impact factor: 5.422

5.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

6.  Interactions between serum titres to filamentous bacteria and their relationship to human periodontal disease.

Authors:  M N Gilmour; R J Nisengard
Journal:  Arch Oral Biol       Date:  1974-11       Impact factor: 2.633

7.  Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.

Authors:  J K Phillips; R Snyderman; S E Mergenhagen
Journal:  J Immunol       Date:  1972-08       Impact factor: 5.422

8.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

9.  Antibody-mediated effects on the periodontium.

Authors:  R J Genco; P A Mashimo; G Krygier; S A Ellison
Journal:  J Periodontol       Date:  1974-05       Impact factor: 6.993

10.  Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.

Authors:  R D Schreiber; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  2 in total

1.  Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula.

Authors:  H Nygren; G Dahlén; L A Nilsson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.